Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

NSE:BIOFILCHEM Revenue

In the fiscal year ending March 31, 2026, Biofil Chemicals and Pharmaceuticals had annual revenue of 314.78M INR, down -6.27%. Biofil Chemicals and Pharmaceuticals had revenue of 76.74M in the quarter ending March 31, 2026, a decrease of -9.32%.

• Revenue: 314.78M
• Revenue Growth: -6.27%
• P/S Ratio: 1.89
• Revenue / Employee: 12.11M
• Employees: 26
• Market Cap: 594.32M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	314.78M	-21.05M	-6.27%
Mar 31, 2025	335.82M	-68.27M	-16.89%
Mar 31, 2024	404.09M	103.74M	34.54%
Mar 31, 2023	300.35M	76.53M	34.19%
Mar 31, 2022	223.82M	-134.27M	-37.50%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error